ECR 2026

Fresh from European Congress of Radiology 2026, Minerva Becker and Carlo Cosimo Quattrocchi share key insights on how emerging evidence is reshaping the use of MRI contrast agents, challenging when gadolinium is truly needed and highlighting next-generation agents that enable meaningful dose reduction without compromising diagnostic performance. They also explore the growing role of AI…

Our oral presentation picks on the theme Rays of Knowledge from the congress in Vienna

Watch Dr. Giles Roditi talk through the history of GBCAs and why optimizing gadolinium dosage is key to good radiology practice.

Dr. Nina Kottler shares her thoughts on how the power of AI might be harnessed to reduce GBCA use, improve patient care, and manage the increasing workload of radiologists.

Dr. Giles Roditi discusses the characteristics of the next-generation GBCAs and the findings of a cardiac subanalysis of the phase 3 QUANTI OBR trial that were presented at ECR 2026.

Guideline recommendations on when GBCA should be used for patients with MS by Dr Àlex Rovira